Efficacy of SUZY forceps for nasogastric tube insertion (randomized, clinical trial)

Efficacy of SUZY forceps for nasogastric tube insertion (randomized, clinical trial) - Efficacy of SUZY forceps for nasogastric tube insertion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016631

Enrollment

Registered

2015-02-25

Start date

2015-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases requiring gastrointestinal and hepato-biliary-pancreatic surgery

Interventions

nasogastric tube insertion with SUZY forceps nasogastric tube insertion with Magill forceps

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing gastro-intestinal, hepato-bilial-pancreatic surgery

Exclusion criteria

Exclusion criteria: patient's refusal, emergency case, a patient with full stomach, tracheostomy, predictable difficult airway, risk of hypoxia due to apnea less than 1 minute, risk of worsening of cardiovascular disease by hemodynamic change induced by McGRATH MAC, risk of hemorrhage due to upper gastrointestinal tract disease, abnormal teeth, pharyngo-laryngeal lesion, coagulopathy or low platelet counts, history of allergy and a case excluded by an attending anesthesiologist

Design outcomes

Primary

Measure	Time frame
time required for nasogastric tube insertion	—

Secondary

Measure	Time frame
success rate, frequencies and degrees of pharyngo-laryngeal complications, hemodynamic changes by nasogastric tube insertion	—

Countries

Japan

Contacts

Public ContactKenta Furutani

Niigata University Medical and Dental Sciences Anesthesiology

kenta-f@med.niigata-u.ac.jp025-227-2328

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026